Financials data is unavailable for this security.
View more
Year on year Merck & Co Inc 's net income fell -97.49% from 14.52bn to 365.00m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 16.78% to 17.27%.
Gross margin | 74.85% |
---|---|
Net profit margin | 3.78% |
Operating margin | 5.99% |
Return on assets | 2.17% |
---|---|
Return on equity | 5.29% |
Return on investment | 2.81% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Merck & Co Inc fell by 5.86bn. However, the company earned 13.01bn from its operations for a Cash Flow Margin of 21.64%. In addition the company used 14.08bn on investing activities and also paid 4.81bn in financing cash flows.
Cash flow per share | 2.44 |
---|---|
Price/Cash flow per share | 53.73 |
Book value per share | 15.94 |
---|---|
Tangible book value per share | 0.6361 |
More ▼
Balance sheet in USDView more
Current ratio | 1.25 |
---|---|
Quick ratio | 0.9935 |
Total debt/total equity | 0.8478 |
---|---|
Total debt/total capital | 0.4584 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 2.84% |
---|---|
Div growth rate (5 year) | 8.26% |
Payout ratio (TTM) | 331.66% |
EPS growth(5 years) | -43.23 |
---|---|
EPS (TTM) vs TTM 1 year ago | -82.59 |
More ▼